Chen, Shi-Dong
You, Jia http://orcid.org/0000-0002-7079-8041
Zhang, Wei
Wu, Bang-Sheng
Ge, Yi-Jun
Xiang, Shi-Tong http://orcid.org/0000-0002-5513-4714
Du, Jing
Kuo, Kevin
Banaschewski, Tobias http://orcid.org/0000-0003-4595-1144
Barker, Gareth J. http://orcid.org/0000-0002-5214-7421
Bokde, Arun L. W. http://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane http://orcid.org/0000-0002-9120-7060
Flor, Herta http://orcid.org/0000-0003-4809-5398
Grigis, Antoine
Garavan, Hugh
Gowland, Penny http://orcid.org/0000-0002-4900-4817
Heinz, Andreas http://orcid.org/0000-0001-5405-9065
Brühl, Rüdiger http://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc http://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère
Artiges, Eric http://orcid.org/0000-0003-4461-7646
Nees, Frauke
Orfanos, Dimitri Papadopoulos http://orcid.org/0000-0002-1242-8990
Lemaitre, Herve http://orcid.org/0000-0002-5952-076X
Paus, Tomáš http://orcid.org/0000-0003-1495-9338
Poustka, Luise
Hohmann, Sarah http://orcid.org/0000-0002-5175-6698
Millenet, Sabina
Baeuchl, Christian
Smolka, Michael N. http://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi http://orcid.org/0000-0002-4600-7158
Walter, Henrik http://orcid.org/0000-0002-9403-6121
Whelan, Robert
Schumann, Gunter http://orcid.org/0000-0002-7740-6469
,
Feng, Jian-Feng http://orcid.org/0000-0001-5987-2258
Dong, Qiang http://orcid.org/0000-0002-3874-0130
Cheng, Wei http://orcid.org/0000-0003-1118-1743
Yu, Jin-Tai http://orcid.org/0000-0002-2532-383X
Article History
Received: 6 February 2023
Accepted: 20 November 2023
First Online: 5 January 2024
Competing interests
: T.B. served in an advisory or consultancy role for eye level, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg, Roche and Takeda. He received conference support or speaker’s fees from Janssen, Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien and Oxford University Press; the current work is unrelated to these relationships. G.J.B. has received honoraria from General Electric Healthcare for teaching on scanner programming courses. L.P. served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fees from Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The current work is unrelated to the above grants and relationships. The remaining authors declare no competing interests.